Sclerotherapy for Craniofacial Venous Malformation.
- Author:
Jung Wook JIN
1
;
Myung Whun SUNG
;
Yune Sung LIM
;
Bum Jung PARK
;
Jong Lyel ROH
;
Weon Jin SEONG
;
Kang Jin LEE
;
Byung Yoon CHOI
;
Kwang Hyun KIM
;
Kyung Won MIN
;
Moon Hee HAN
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, Seoul National University, College of Medicine, Seoul, Korea. mwsung@snu.ac,kr
- Publication Type:Original Article
- Keywords:
Venous malformation;
Sclerotherapy
- MeSH:
Angiography;
Dyspnea;
Ethiodized Oil;
Head;
Humans;
Injections, Intralesional;
Magnetic Resonance Imaging;
Neck;
Retrospective Studies;
Sclerotherapy*;
Seoul;
Surgery, Plastic
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2002;45(4):387-392
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Venous malformations are one of the most common vascular anomalies, and are more frequently found in head and neck region. Various treatment options are available, and intralesional injection of sclerosant is the commonest primary treatment modality. We reviewed 20 cases of venous malformation treated with sclerotherapy at Seoul National University Hospital. MATERIALS AND METHODS: Twenty cases of venous malformation in head and neck were reviewed retrospectively, which had been managed with sclerotherapy from January 1991 to July 2001. The patients were treated at the department of otolaryngology-Head and Neck Surgery or plastic surgery of Seoul National University Hospital. Emulsion of Ethamolin and Lipiodol was used as a sclerosing agent. Some patients received surgical treatment after sclerotherapy. All of the patients received direct-puncture venography(Digital subtraction angiography) before sclerotherapy. Treatment results were evaluated by using MRI, angiography, or CT. If the reduction of volume of mass was more than 50 percent after sclerotherapy, we regarded the result as effective, if less than 50 percents, non-effective. Statistical analysis was done using SPSS10.0 for windows. RESULTS: Among twenty patients, there were eight males(40%), and twelve females(60%). Ages at the beginning of treatment ranged from six to thirty-eight years(mean age:20.6 years). The most common site of lesions was cheek(in 12 cases). Mass sizes(largest diameter) ranged from 2 cm to 20 cm. Nine cases were managed with both sclerotherapy and surgical excision, and eleven cases, only with sclerotherapy. Thirteen cases(65%) responded well to sclerotherapy(volume reduction>or=50%). There was no major complication. Tenderness, induration, swelling, and pain were reported as post-sclerotherapy complaints. Mild dyspnea occurred in one case, and the patient was managed at ICU shortly without fatal event. CONCLUSION: Sclerotherapy with or without surgical excision was an effective treatment modality for venous malformation, with minimal risk of major complications. There were no significant differences in the treatment results according to the initial size of the lesions.
